- Home
- BRIA vs ELUT Comparison
BRIA vs ELUT Comparison
Compare BRIA & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRIA
- ELUT
- Stock Information
- Founded
- BRIA 2011
- ELUT 2015
- Country
- BRIA Singapore
- ELUT United States
- Employees
- BRIA N/A
- ELUT N/A
- Industry
- BRIA
- ELUT Medical Specialities
- Sector
- BRIA
- ELUT Health Care
- Exchange
- BRIA NYSE
- ELUT Nasdaq
- Market Cap
- BRIA 99.8M
- ELUT 108.2M
- IPO Year
- BRIA 2024
- ELUT 2020
- Fundamental
- Price
- BRIA $3.65
- ELUT $3.20
- Analyst Decision
- BRIA
- ELUT Strong Buy
- Analyst Count
- BRIA 0
- ELUT 2
- Target Price
- BRIA N/A
- ELUT $10.00
- AVG Volume (30 Days)
- BRIA 38.6K
- ELUT 46.3K
- Earning Date
- BRIA 02-15-2025
- ELUT 03-06-2025
- Dividend Yield
- BRIA N/A
- ELUT N/A
- EPS Growth
- BRIA N/A
- ELUT N/A
- EPS
- BRIA 92.24
- ELUT N/A
- Revenue
- BRIA $55,755,669.00
- ELUT $24,782,000.00
- Revenue This Year
- BRIA N/A
- ELUT $4.29
- Revenue Next Year
- BRIA N/A
- ELUT $32.21
- P/E Ratio
- BRIA $0.04
- ELUT N/A
- Revenue Growth
- BRIA 8.03
- ELUT N/A
- 52 Week Low
- BRIA $3.21
- ELUT $2.28
- 52 Week High
- BRIA $4.38
- ELUT $5.24
- Technical
- Relative Strength Index (RSI)
- BRIA N/A
- ELUT 40.50
- Support Level
- BRIA N/A
- ELUT $2.86
- Resistance Level
- BRIA N/A
- ELUT $3.33
- Average True Range (ATR)
- BRIA 0.00
- ELUT 0.30
- MACD
- BRIA 0.00
- ELUT -0.05
- Stochastic Oscillator
- BRIA 0.00
- ELUT 24.64
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.